Trend Health Partners

Trend Health Partners

Payer-provider payment integrity platform and analytics

Overview

Trend Health Partners delivers technology-enabled payment integrity and revenue cycle management solutions for payers and providers in the U.S. healthcare market. Its TRENDConnect analytics and workflow platform identifies and resolves inaccurate payments, supports denial management, and clears credit balances, acting as a neutral space for payer-provider collaboration to reduce administrative costs. The company strengthens its platform by integrating the CAVO AI-powered medical record-review tools for utilization management and DRG reviews, combining clinical and non-clinical data analytics. It differentiates itself through payer-provider collaboration, a focus on getting payments right upfront to prevent downstream issues, an employee-owned structure, and growth via strategic investments and acquisitions with the aim of lowering costs and improving reimbursement efficiency.

About Trend Health Partners

Simplify's Rating
Why Trend Health Partners is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Fintech

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Cockeysville, Maryland

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven analytics expand CAVO adoption per KLAS 2025 report.
  • Over 50 health plans and 1,000 hospitals drive market share.
  • Lone View Capital investment fuels post-2023 acquisition growth.

What critics are saying

  • Optum's vertical integration captures customers with pricing power.
  • CMS 2025 real-time adjudication commoditizes payment services.
  • Payer-provider consolidation like CVS-Aetna eliminates collaboration need.

What makes Trend Health Partners unique

  • TRENDConnect enables payer-provider collaboration on payment accuracy.
  • CAVO AI streamlines medical record reviews for utilization management.
  • Neutral platform resolves credit balances and denials proactively.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Parental Leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

1%
Business Wire
Apr 10th, 2024
Lone View Capital Raises $850 Million For Inaugural Investment Fund

LOS ANGELES--(BUSINESS WIRE)--Lone View Capital (“Lone View” or the “Firm”), a growth-oriented private equity firm investing across the technology ecosystem, today announced the close of its inaugural fund, Lone View Capital Fund I (“Fund I”). Fund I closed with total committed capital of $850 million, bringing Lone View’s assets under management to approximately $1.1 billion. Fund I is backed by a diverse group of experienced investors, including university endowments, sovereign wealth funds, charitable foundations, pension funds, asset managers, insurance companies and family offices. Lone View’s integrated team of seasoned investors and operators leverage their deep domain expertise to partner with exceptional management teams to build, transform and grow market-leading software, information services and technology-enabled businesses. The Firm was co-founded by Rishi Chandna and Doug Ceto, who worked closely together at Golden Gate Capital, where they led the Software Services vertical. They were also joined by Jim Schaper, an experienced multi-time CEO and former Operating Executive at Golden Gate Capital

Technical.ly
Dec 20th, 2023
Baltimore Money Moves: Biotech Wins Big (Again)

Money Moves is a column where we chart the raises, mergers and other funding news of tech companies across the region on the third Wednesday of the month. Have a tip? Email us at [email protected]. Full disclosure: This article mentions investments by TEDCO, a Technical.ly Ecosystem Builder client. That relationship is unrelated to this report.Big biotech raises and grantsGlycoMantra, a University of Maryland, Baltimore startup, received a $3.7 million SBIR Phase II grant from the National Institute of Diabetes and Digestive and Kidney Diseases. The funding aims to advance the development of therapeutics for metastatic castration-resistant prostate cancer, liver fibrosis and type 2 diabetes. Irazu Oncology, a biotech company using a platform developed by University of Maryland, Baltimore researchers for cancer vaccine development, has reportedly secured $2.6 million in debt from an undisclosed source, as reported by citybiz+

Yahoo Finance
Dec 16th, 2023
TREND Health Partners Acquires Advent Health Partners

COCKEYSVILLE, Md., December 15, 2023--TREND Health Partners ("TREND"), a rapidly growing provider of healthcare credit balance management and payment accuracy solutions, announced today that it has acquired Advent Health Partners, Inc. ("Advent"). This strategic combination solidifies TREND’s position as a leading AI-driven payment accuracy and revenue integrity platform for healthcare payers and providers.

Investor's Review
Dec 15th, 2023
TREND Health Partners Acquires Advent Health Partners

TREND Health Partners acquires Advent Health Partners.

Business Wire
Oct 24th, 2023
TREND Health Partners Accelerates Innovation Agenda with Acquisition of PrecisionGx

TREND Health Partners (“TREND”) announced today that it has acquired PrecisionGx, a rapidly growing provider of next-generation artificial intelligenc

Recently Posted Jobs

Sign up to get curated job recommendations

Trend Health Partners is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →